Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Cohort Registry Study of Intravenous Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours of Symptom Onset (PRISM)

NCT07787325 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Anhui Medical University as lead sponsor.

NCT NCT07787325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07787325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Cohort Registry Study of Intravenous Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours of Symptom Onset (PRISM)
Lead sponsor
The First Affiliated Hospital of Anhui Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 11, 2026
Completion date
August 31, 2029
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke